HeartSciences Inc. Warrant
HSCSW
About: HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Employees: 12
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
71% more capital invested
Capital invested by funds: $23.1K [Q1] → $39.5K (+$16.3K) [Q2]
22.81% less ownership
Funds ownership: 51.04% [Q1] → 28.23% (-22.81%) [Q2]
33% less funds holding
Funds holding: 3 [Q1] → 2 (-1) [Q2]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Financial journalist opinion
We haven’t received any recent news articles for HSCSW